$24.89 (3.49%)

Volume: 372.317k

Closed: Mar 21, 2023

Hollow Logo Score: 0.511
Collegium Pharmaceutical Stock
$24.89 (3.49%)

Volume: 372.317k

Closed: Mar 21, 2023

Score Hollow Logo 0.511

Collegium Pharmaceutical Stock Company Profile

100 Technology Center Drive, Suite 300

Stoughton MA 02072

781 713 3699



Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE